HEADER HYDROLASE 10-AUG-05 2AMP
TITLE CRYSTAL STRUCTURE OF PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS MPRO
TITLE 2 IN COMPLEX WITH AN INHIBITOR N1
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 3C-LIKE PROTEINASE;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: TGEV MAIN PROTEASE, 3CL-PRO;
COMPND 5 EC: 3.4.22.-;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: TRANSMISSIBLE GASTROENTERITIS VIRUS;
SOURCE 3 ORGANISM_TAXID: 11149;
SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-1
KEYWDS ANTI-PARALLEL B-BARREL, ANTI-PARALLEL A-HELICES, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR H.YANG,X.XUE,K.YANG,Q.ZHAO,M.BARTLAM,Z.RAO
REVDAT 4 23-OCT-24 2AMP 1 REMARK SEQADV LINK
REVDAT 3 24-FEB-09 2AMP 1 VERSN
REVDAT 2 04-OCT-05 2AMP 1 JRNL
REVDAT 1 13-SEP-05 2AMP 0
JRNL AUTH H.YANG,W.XIE,X.XUE,K.YANG,J.MA,W.LIANG,Q.ZHAO,Z.ZHOU,D.PEI,
JRNL AUTH 2 J.ZIEBUHR,R.HILGENFELD,K.Y.YUEN,L.WONG,G.GAO,S.CHEN,Z.CHEN,
JRNL AUTH 3 D.MA,M.BARTLAM,Z.RAO
JRNL TITL DESIGN OF WIDE-SPECTRUM INHIBITORS TARGETING CORONAVIRUS
JRNL TITL 2 MAIN PROTEASES.
JRNL REF PLOS BIOL. V. 3 324 2005
JRNL REFN ISSN 1544-9173
JRNL PMID 16128623
JRNL DOI 10.1371/JOURNAL.PBIO.0030324
REMARK 2
REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 17871
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.234
REMARK 3 FREE R VALUE : 0.271
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 868
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4594
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 88
REMARK 3 SOLVENT ATOMS : 90
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.020
REMARK 3 BOND ANGLES (DEGREES) : 1.940
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2AMP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-AUG-05.
REMARK 100 THE DEPOSITION ID IS D_1000034073.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-OCT-04
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 8.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : OSMIC MIRROR
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18149
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75
REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.60
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: HEPES, (NH4)2SO4, MPD, DTT, DIOXANE,
REMARK 280 PH 8.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.29450
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.17250
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.11950
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.17250
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.29450
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.11950
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 4660 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 25390 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -1
REMARK 465 SER A 0
REMARK 465 ASN A 300
REMARK 465 LEU A 301
REMARK 465 GLN A 302
REMARK 465 GLY B -1
REMARK 465 SER B 0
REMARK 465 ASN B 300
REMARK 465 LEU B 301
REMARK 465 GLN B 302
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O ASN B 153 N ILE B 155 1.96
REMARK 500 OG SER B 10 OE2 GLU B 14 1.97
REMARK 500 O TYR B 53 N ASN B 55 2.09
REMARK 500 O ASP B 245 N PHE B 247 2.09
REMARK 500 NH2 ARG A 4 O LYS B 136 2.13
REMARK 500 O LYS A 136 NH1 ARG B 4 2.17
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 OE1 GLU A 54 NZ LYS A 260 2455 2.15
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 VAL A 13 CB VAL A 13 CG1 -0.194
REMARK 500 VAL A 13 CB VAL A 13 CG2 -0.158
REMARK 500 GLU A 14 CD GLU A 14 OE1 -0.091
REMARK 500 GLU A 14 CD GLU A 14 OE2 -0.091
REMARK 500 PRO A 15 CB PRO A 15 CG -0.301
REMARK 500 VAL A 20 CB VAL A 20 CG2 -0.186
REMARK 500 TYR A 22 CE1 TYR A 22 CZ -0.109
REMARK 500 TYR A 22 CZ TYR A 22 CE2 -0.080
REMARK 500 TYR A 22 CE2 TYR A 22 CD2 -0.092
REMARK 500 VAL A 26 CB VAL A 26 CG1 -0.148
REMARK 500 MET A 161 C HIS A 162 N -0.258
REMARK 500 HIS A 162 C HIS A 163 N 0.175
REMARK 500 LEU A 262 C ASP A 263 N 0.143
REMARK 500 LYS B 5 CE LYS B 5 NZ -0.153
REMARK 500 MET B 6 CG MET B 6 SD -0.235
REMARK 500 MET B 6 SD MET B 6 CE -0.642
REMARK 500 PRO B 9 CB PRO B 9 CG -0.323
REMARK 500 MET B 190 SD MET B 190 CE 0.613
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 15 C - N - CD ANGL. DEV. = -14.1 DEGREES
REMARK 500 LYS A 82 N - CA - C ANGL. DEV. = -17.4 DEGREES
REMARK 500 LEU B 3 CA - CB - CG ANGL. DEV. = 16.9 DEGREES
REMARK 500 MET B 190 CG - SD - CE ANGL. DEV. = 10.1 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 9 143.35 -36.33
REMARK 500 LEU A 27 -149.07 -152.87
REMARK 500 SER A 45 -94.62 -55.49
REMARK 500 HIS A 63 -7.97 -47.45
REMARK 500 SER A 66 121.44 179.99
REMARK 500 ASN A 70 -128.30 69.80
REMARK 500 SER A 78 145.56 -173.64
REMARK 500 GLU A 118 43.22 36.12
REMARK 500 SER A 123 158.56 175.99
REMARK 500 LYS A 136 70.21 -103.32
REMARK 500 ILE A 140 -164.09 -111.28
REMARK 500 CYS A 144 139.61 -39.74
REMARK 500 ASN A 153 -6.99 63.25
REMARK 500 HIS A 163 -49.05 -143.39
REMARK 500 ASP A 186 47.04 -73.53
REMARK 500 PRO A 188 49.73 -73.84
REMARK 500 THR A 195 134.12 -38.16
REMARK 500 ARG A 216 -23.17 -144.35
REMARK 500 PHE A 218 12.25 -67.14
REMARK 500 SER A 243 115.10 -164.45
REMARK 500 LYS A 270 36.83 -88.24
REMARK 500 PHE A 272 6.54 -69.35
REMARK 500 SER A 279 -13.44 73.75
REMARK 500 ILE A 293 -74.71 -61.69
REMARK 500 MET A 296 -165.18 -101.27
REMARK 500 TYR A 297 106.05 -51.89
REMARK 500 TYR B 22 89.04 -177.06
REMARK 500 HIS B 41 -2.16 -47.15
REMARK 500 VAL B 50 133.71 -25.12
REMARK 500 TYR B 53 -115.79 -64.84
REMARK 500 GLU B 54 -71.75 16.07
REMARK 500 ARG B 61 88.88 -64.50
REMARK 500 LEU B 62 -33.74 -32.71
REMARK 500 PHE B 65 160.69 -47.07
REMARK 500 ASN B 70 -154.28 65.82
REMARK 500 ASN B 71 47.64 -92.85
REMARK 500 VAL B 77 -83.81 -105.75
REMARK 500 SER B 78 -169.93 -104.02
REMARK 500 ALA B 79 120.81 -175.07
REMARK 500 ASN B 91 39.97 -90.00
REMARK 500 GLN B 92 86.11 -172.98
REMARK 500 LYS B 103 -160.53 -172.54
REMARK 500 VAL B 127 -156.82 -136.64
REMARK 500 SER B 138 48.36 -176.31
REMARK 500 ALA B 141 106.93 -50.83
REMARK 500 ASN B 153 110.29 65.90
REMARK 500 PRO B 188 55.90 -69.00
REMARK 500 THR B 195 146.58 -35.27
REMARK 500 ASN B 213 35.17 -89.99
REMARK 500 THR B 222 141.03 147.27
REMARK 500
REMARK 500 THIS ENTRY HAS 61 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 GLY B 2 LEU B 3 138.88
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I12 A 1001
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE I12 B 2001
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1UJ1 RELATED DB: PDB
REMARK 900 RELATED ID: 2AMD RELATED DB: PDB
REMARK 900 THE SAME PROTEIN WITH 9IN
REMARK 900 RELATED ID: 2AMQ RELATED DB: PDB
REMARK 900 THE SAME PROTEIN WITH 3IH
DBREF 2AMP A 1 302 UNP Q9IW06 R1AB_CVPPU 2879 3180
DBREF 2AMP B 1 302 UNP Q9IW06 R1AB_CVPPU 2879 3180
SEQADV 2AMP GLY A -1 UNP Q9IW06 CLONING ARTIFACT
SEQADV 2AMP SER A 0 UNP Q9IW06 CLONING ARTIFACT
SEQADV 2AMP GLY B -1 UNP Q9IW06 CLONING ARTIFACT
SEQADV 2AMP SER B 0 UNP Q9IW06 CLONING ARTIFACT
SEQRES 1 A 304 GLY SER SER GLY LEU ARG LYS MET ALA GLN PRO SER GLY
SEQRES 2 A 304 LEU VAL GLU PRO CYS ILE VAL ARG VAL SER TYR GLY ASN
SEQRES 3 A 304 ASN VAL LEU ASN GLY LEU TRP LEU GLY ASP GLU VAL ILE
SEQRES 4 A 304 CYS PRO ARG HIS VAL ILE ALA SER ASP THR THR ARG VAL
SEQRES 5 A 304 ILE ASN TYR GLU ASN GLU MET SER SER VAL ARG LEU HIS
SEQRES 6 A 304 ASN PHE SER VAL SER LYS ASN ASN VAL PHE LEU GLY VAL
SEQRES 7 A 304 VAL SER ALA ARG TYR LYS GLY VAL ASN LEU VAL LEU LYS
SEQRES 8 A 304 VAL ASN GLN VAL ASN PRO ASN THR PRO GLU HIS LYS PHE
SEQRES 9 A 304 LYS SER ILE LYS ALA GLY GLU SER PHE ASN ILE LEU ALA
SEQRES 10 A 304 CYS TYR GLU GLY CYS PRO GLY SER VAL TYR GLY VAL ASN
SEQRES 11 A 304 MET ARG SER GLN GLY THR ILE LYS GLY SER PHE ILE ALA
SEQRES 12 A 304 GLY THR CYS GLY SER VAL GLY TYR VAL LEU GLU ASN GLY
SEQRES 13 A 304 ILE LEU TYR PHE VAL TYR MET HIS HIS LEU GLU LEU GLY
SEQRES 14 A 304 ASN GLY SER HIS VAL GLY SER ASN PHE GLU GLY GLU MET
SEQRES 15 A 304 TYR GLY GLY TYR GLU ASP GLN PRO SER MET GLN LEU GLU
SEQRES 16 A 304 GLY THR ASN VAL MET SER SER ASP ASN VAL VAL ALA PHE
SEQRES 17 A 304 LEU TYR ALA ALA LEU ILE ASN GLY GLU ARG TRP PHE VAL
SEQRES 18 A 304 THR ASN THR SER MET SER LEU GLU SER TYR ASN THR TRP
SEQRES 19 A 304 ALA LYS THR ASN SER PHE THR GLU LEU SER SER THR ASP
SEQRES 20 A 304 ALA PHE SER MET LEU ALA ALA LYS THR GLY GLN SER VAL
SEQRES 21 A 304 GLU LYS LEU LEU ASP SER ILE VAL ARG LEU ASN LYS GLY
SEQRES 22 A 304 PHE GLY GLY ARG THR ILE LEU SER TYR GLY SER LEU CYS
SEQRES 23 A 304 ASP GLU PHE THR PRO THR GLU VAL ILE ARG GLN MET TYR
SEQRES 24 A 304 GLY VAL ASN LEU GLN
SEQRES 1 B 304 GLY SER SER GLY LEU ARG LYS MET ALA GLN PRO SER GLY
SEQRES 2 B 304 LEU VAL GLU PRO CYS ILE VAL ARG VAL SER TYR GLY ASN
SEQRES 3 B 304 ASN VAL LEU ASN GLY LEU TRP LEU GLY ASP GLU VAL ILE
SEQRES 4 B 304 CYS PRO ARG HIS VAL ILE ALA SER ASP THR THR ARG VAL
SEQRES 5 B 304 ILE ASN TYR GLU ASN GLU MET SER SER VAL ARG LEU HIS
SEQRES 6 B 304 ASN PHE SER VAL SER LYS ASN ASN VAL PHE LEU GLY VAL
SEQRES 7 B 304 VAL SER ALA ARG TYR LYS GLY VAL ASN LEU VAL LEU LYS
SEQRES 8 B 304 VAL ASN GLN VAL ASN PRO ASN THR PRO GLU HIS LYS PHE
SEQRES 9 B 304 LYS SER ILE LYS ALA GLY GLU SER PHE ASN ILE LEU ALA
SEQRES 10 B 304 CYS TYR GLU GLY CYS PRO GLY SER VAL TYR GLY VAL ASN
SEQRES 11 B 304 MET ARG SER GLN GLY THR ILE LYS GLY SER PHE ILE ALA
SEQRES 12 B 304 GLY THR CYS GLY SER VAL GLY TYR VAL LEU GLU ASN GLY
SEQRES 13 B 304 ILE LEU TYR PHE VAL TYR MET HIS HIS LEU GLU LEU GLY
SEQRES 14 B 304 ASN GLY SER HIS VAL GLY SER ASN PHE GLU GLY GLU MET
SEQRES 15 B 304 TYR GLY GLY TYR GLU ASP GLN PRO SER MET GLN LEU GLU
SEQRES 16 B 304 GLY THR ASN VAL MET SER SER ASP ASN VAL VAL ALA PHE
SEQRES 17 B 304 LEU TYR ALA ALA LEU ILE ASN GLY GLU ARG TRP PHE VAL
SEQRES 18 B 304 THR ASN THR SER MET SER LEU GLU SER TYR ASN THR TRP
SEQRES 19 B 304 ALA LYS THR ASN SER PHE THR GLU LEU SER SER THR ASP
SEQRES 20 B 304 ALA PHE SER MET LEU ALA ALA LYS THR GLY GLN SER VAL
SEQRES 21 B 304 GLU LYS LEU LEU ASP SER ILE VAL ARG LEU ASN LYS GLY
SEQRES 22 B 304 PHE GLY GLY ARG THR ILE LEU SER TYR GLY SER LEU CYS
SEQRES 23 B 304 ASP GLU PHE THR PRO THR GLU VAL ILE ARG GLN MET TYR
SEQRES 24 B 304 GLY VAL ASN LEU GLN
HET I12 A1001 44
HET I12 B2001 44
HETNAM I12 N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]-L-ALANYL-L-VALYL-
HETNAM 2 I12 N~1~-((1S)-4-ETHOXY-4-OXO-1-{[(3S)-2-OXOPYRROLIDIN-3-
HETNAM 3 I12 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE
HETSYN I12 (E)-(S)-4-[(S)-4-METHYL-2-((S)-3-METHYL-2{(S)-2-[(5-
HETSYN 2 I12 METHYL-ISOXAZOLE-3- CARBONYL)-AMINO]-PROPIONYLAMINO}-
HETSYN 3 I12 BUTYRYLAMINO)-PENTANOYLAMINO]-5-((S)-2- OXO-
HETSYN 4 I12 PYRROLIDIN-3-YL)-PENT-2-ENOIC ACID ETHYL ESTER
FORMUL 3 I12 2(C30 H46 N6 O8)
FORMUL 5 HOH *90(H2 O)
HELIX 1 1 SER A 10 GLU A 14 5 5
HELIX 2 2 HIS A 41 ILE A 43 5 3
HELIX 3 3 ASN A 52 SER A 59 1 8
HELIX 4 4 VAL A 60 HIS A 63 5 4
HELIX 5 5 MET A 180 TYR A 184 5 5
HELIX 6 6 SER A 199 ASN A 213 1 15
HELIX 7 7 SER A 225 THR A 235 1 11
HELIX 8 8 SER A 243 ALA A 246 5 4
HELIX 9 9 PHE A 247 GLY A 255 1 9
HELIX 10 10 SER A 257 ASN A 269 1 13
HELIX 11 11 THR A 288 MET A 296 1 9
HELIX 12 12 VAL B 13 PRO B 15 5 3
HELIX 13 13 HIS B 41 ILE B 43 5 3
HELIX 14 14 TYR B 53 VAL B 60 5 8
HELIX 15 15 ARG B 61 PHE B 65 5 5
HELIX 16 16 MET B 180 TYR B 184 5 5
HELIX 17 17 SER B 199 ASN B 213 1 15
HELIX 18 18 SER B 225 ASN B 236 1 12
HELIX 19 19 PHE B 247 THR B 254 1 8
HELIX 20 20 SER B 257 ASN B 269 1 13
HELIX 21 21 THR B 288 MET B 296 1 9
SHEET 1 A 7 VAL A 72 LEU A 74 0
SHEET 2 A 7 PHE A 65 LYS A 69 -1 N VAL A 67 O LEU A 74
SHEET 3 A 7 ILE A 17 TYR A 22 -1 N ARG A 19 O SER A 68
SHEET 4 A 7 ASN A 25 LEU A 32 -1 O LEU A 27 N VAL A 20
SHEET 5 A 7 GLU A 35 PRO A 39 -1 O GLU A 35 N LEU A 32
SHEET 6 A 7 ASN A 85 VAL A 90 -1 O LEU A 86 N CYS A 38
SHEET 7 A 7 VAL A 76 LYS A 82 -1 N VAL A 77 O LYS A 89
SHEET 1 B 5 HIS A 100 PHE A 102 0
SHEET 2 B 5 ILE A 155 GLU A 165 1 O LEU A 156 N LYS A 101
SHEET 3 B 5 VAL A 147 GLU A 152 -1 N GLY A 148 O TYR A 160
SHEET 4 B 5 SER A 110 TYR A 117 -1 N ASN A 112 O TYR A 149
SHEET 5 B 5 CYS A 120 ASN A 128 -1 O CYS A 120 N TYR A 117
SHEET 1 C 3 HIS A 100 PHE A 102 0
SHEET 2 C 3 ILE A 155 GLU A 165 1 O LEU A 156 N LYS A 101
SHEET 3 C 3 HIS A 171 SER A 174 -1 O VAL A 172 N LEU A 164
SHEET 1 D 5 ILE B 17 TYR B 22 0
SHEET 2 D 5 ASN B 25 LEU B 32 -1 O GLY B 29 N VAL B 18
SHEET 3 D 5 GLU B 35 PRO B 39 -1 O ILE B 37 N LEU B 30
SHEET 4 D 5 ASN B 85 VAL B 90 -1 O LEU B 86 N CYS B 38
SHEET 5 D 5 VAL B 76 LYS B 82 -1 N VAL B 77 O LYS B 89
SHEET 1 E 2 VAL B 67 LYS B 69 0
SHEET 2 E 2 VAL B 72 LEU B 74 -1 O VAL B 72 N LYS B 69
SHEET 1 F 5 HIS B 100 PHE B 102 0
SHEET 2 F 5 LEU B 156 GLU B 165 1 O LEU B 156 N LYS B 101
SHEET 3 F 5 VAL B 147 LEU B 151 -1 N VAL B 150 O TYR B 157
SHEET 4 F 5 SER B 110 TYR B 117 -1 N LEU B 114 O VAL B 147
SHEET 5 F 5 CYS B 120 ASN B 128 -1 O VAL B 127 N PHE B 111
SHEET 1 G 3 HIS B 100 PHE B 102 0
SHEET 2 G 3 LEU B 156 GLU B 165 1 O LEU B 156 N LYS B 101
SHEET 3 G 3 HIS B 171 SER B 174 -1 O VAL B 172 N LEU B 164
LINK SG CYS A 144 C21 I12 A1001 1555 1555 1.81
LINK SG CYS B 144 C21 I12 B2001 1555 1555 1.82
SITE 1 AC1 16 THR A 47 ILE A 51 PHE A 139 ILE A 140
SITE 2 AC1 16 GLY A 142 CYS A 144 HIS A 162 HIS A 163
SITE 3 AC1 16 LEU A 164 GLU A 165 HIS A 171 ASP A 186
SITE 4 AC1 16 PRO A 188 SER A 189 MET A 190 HOH A1009
SITE 1 AC2 17 THR B 47 ILE B 51 PHE B 139 ILE B 140
SITE 2 AC2 17 ALA B 141 GLY B 142 CYS B 144 HIS B 162
SITE 3 AC2 17 HIS B 163 LEU B 164 GLU B 165 GLY B 167
SITE 4 AC2 17 HIS B 171 ASP B 186 PRO B 188 SER B 189
SITE 5 AC2 17 LYS B 270
CRYST1 66.589 90.239 110.345 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015017 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011082 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009062 0.00000